Sovenyr
Get early access
Signal
2026-07-19
NIH RePORTER
A Novel Synthetically Engineered Oral Immunotherapy for Treating Ulcerative Colitis
Part of
Innovative Biologic Cancer Therapeutics
Open primary source
See the whole picture